ATE349513T1 - Verfahren zur homogenen masskultivierung von t- lymphozyten - Google Patents

Verfahren zur homogenen masskultivierung von t- lymphozyten

Info

Publication number
ATE349513T1
ATE349513T1 AT03776860T AT03776860T ATE349513T1 AT E349513 T1 ATE349513 T1 AT E349513T1 AT 03776860 T AT03776860 T AT 03776860T AT 03776860 T AT03776860 T AT 03776860T AT E349513 T1 ATE349513 T1 AT E349513T1
Authority
AT
Austria
Prior art keywords
lymphocytes
homogeneous mass
mass cultivation
refers
lymphocytic
Prior art date
Application number
AT03776860T
Other languages
English (en)
Inventor
Silvia Trasciatti
Maria Luisa Nolli
Luigi Cavenaghi
Bernardi Nadia De
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Application granted granted Critical
Publication of ATE349513T1 publication Critical patent/ATE349513T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT03776860T 2002-10-04 2003-10-06 Verfahren zur homogenen masskultivierung von t- lymphozyten ATE349513T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002118A ITMI20022118A1 (it) 2002-10-04 2002-10-04 Procedimento per la coltura su larga scala di t-linfociti in un sistema omogeneo.

Publications (1)

Publication Number Publication Date
ATE349513T1 true ATE349513T1 (de) 2007-01-15

Family

ID=32051228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776860T ATE349513T1 (de) 2002-10-04 2003-10-06 Verfahren zur homogenen masskultivierung von t- lymphozyten

Country Status (14)

Country Link
US (1) US7678571B2 (de)
EP (1) EP1554374B1 (de)
JP (1) JP2006500936A (de)
CN (1) CN100535107C (de)
AT (1) ATE349513T1 (de)
AU (1) AU2003286134B2 (de)
CA (1) CA2500408C (de)
DE (1) DE60310748T2 (de)
DK (1) DK1554374T3 (de)
ES (1) ES2279190T3 (de)
IT (1) ITMI20022118A1 (de)
PT (1) PT1554374E (de)
SI (1) SI1554374T1 (de)
WO (1) WO2004031370A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101302491B (zh) * 2007-05-09 2011-09-14 王歈 高效扩增活化淋巴细胞的方法和培养系统
PL3532607T3 (pl) 2016-10-26 2024-07-01 Iovance Biotherapeutics, Inc. Restymulacja kriokonserwowanych limfocytów naciekających guza nowotworowego
JOP20190224A1 (ar) 2017-03-29 2019-09-26 Iovance Biotherapeutics Inc عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي
US11254913B1 (en) 2017-03-29 2022-02-22 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
AR112072A1 (es) 2017-06-05 2019-09-18 Iovance Biotherapeutics Inc Métodos de uso de linfocitos infiltrantes de tumor en melanoma doble refractario
US11713446B2 (en) 2018-01-08 2023-08-01 Iovance Biotherapeutics, Inc. Processes for generating TIL products enriched for tumor antigen-specific T-cells
KR102956273B1 (ko) 2018-01-08 2026-04-24 이오반스 바이오테라퓨틱스, 인크. 종양 항원-특이적 t-세포에 대해 풍부화된 til 생성물의 생성 방법
EP3784254A1 (de) 2018-04-27 2021-03-03 Iovance Biotherapeutics, Inc. Geschlossenes verfahren zur expansion und geneditierung von tumorinfiltrierenden lymphozyten und verwendungen davon in der immuntherapie
WO2019217753A1 (en) 2018-05-10 2019-11-14 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
TW202039831A (zh) 2018-11-05 2020-11-01 美商艾歐凡斯生物治療公司 對抗ｐｄ－１抗體呈現難治性之非小細胞肺癌（ｎｓｃｌｃ）病患之治療
CR20210295A (es) 2018-11-05 2021-07-09 Iovance Biotherapeutics Inc Procesos para la producción de linfocitos infiltrantes de tumor y usos de estos en inmunoterapia
EP4225330A1 (de) 2020-10-06 2023-08-16 Iovance Biotherapeutics, Inc. Behandlung von nsclc-patienten mit tumorinfiltrierenden lymphozytentherapien
WO2022204564A2 (en) 2021-03-25 2022-09-29 Iovance Biotherapeutics, Inc. Methods and compositions for t-cell coculture potency assays and use with cell therapy products
WO2023201369A1 (en) 2022-04-15 2023-10-19 Iovance Biotherapeutics, Inc. Til expansion processes using specific cytokine combinations and/or akti treatment
CN115558641B (zh) * 2022-11-14 2023-05-12 四川新生命干细胞科技股份有限公司 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4403993A (en) * 1992-06-05 1994-01-04 Synergen, Inc. T-cell monocyte inducing proteins (TMIPS)
EP0697875B1 (de) * 1993-05-14 2002-01-16 THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY Verwendung von modifizierten tall-104 zellen zur behandlung von krebs und viralen krankheiten
US5789147A (en) * 1994-12-05 1998-08-04 New York Blood Center, Inc. Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US6022344A (en) * 1997-12-04 2000-02-08 Npbi International B.V. Cryopreservation bag

Also Published As

Publication number Publication date
ES2279190T3 (es) 2007-08-16
EP1554374B1 (de) 2006-12-27
DE60310748T2 (de) 2007-10-11
ITMI20022118A1 (it) 2004-04-05
CA2500408C (en) 2015-02-17
HK1076294A1 (en) 2006-01-13
EP1554374A1 (de) 2005-07-20
AU2003286134B2 (en) 2008-10-16
US20060034802A1 (en) 2006-02-16
CA2500408A1 (en) 2004-04-15
WO2004031370A1 (en) 2004-04-15
CN100535107C (zh) 2009-09-02
DK1554374T3 (da) 2007-05-07
DE60310748D1 (de) 2007-02-08
PT1554374E (pt) 2007-03-30
SI1554374T1 (sl) 2007-06-30
JP2006500936A (ja) 2006-01-12
AU2003286134A1 (en) 2004-04-23
CN1703506A (zh) 2005-11-30
US7678571B2 (en) 2010-03-16

Similar Documents

Publication Publication Date Title
DE60310748D1 (de) Verfahren zur homogenen masskultivierung von t-lymphozyten
DE60238863D1 (de) Vorrichtung und verfahren zur fermentation in hohen zelldichten
ATE365793T1 (de) Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
DK1664318T3 (da) L-aminosyre-producerende mikroorganisme og fremgangsmåde til fremstilling af L-aminosyre
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
SG158025A1 (en) Growth medium c. histolyticum without ingredients of mamalian sources
DE50312269D1 (de) Verfahren und vorrichtung zum züchten von zellen
MX2007005132A (es) Medios libres de proteina animal para cultivo de celulas.
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
SE0850111L (sv) Förfarande för differentiering av stamceller till celler av den endodermala och pankreatiska utvecklingslinjen
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
ATE414144T1 (de) Kulturen von e1-immortalisierten zellen und verfahren zu deren kultivierung zur erhöhung der produktausbeuten davon
AU2003252396A8 (en) Apparatus for environment of cultivating/culturing plant, cultivation/culture method and cultivation/culture apparatus
DK1495112T3 (da) Cellekulturmedium
CL2010000774A1 (es) Medio para el cultivo de celulas de mamiferos que comprende ademas de los nutrientes habituales de los medios de cultivo basales para cultivo de celulas de mamiferos, sobrenadante de la fraccion ii+iii del plasma humano segun el metodo de cohn; procedimiento de preparacion; y su uso.
EP1506005A4 (de) Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen
EP1541670A4 (de) MIKROKAMMER FüR NERVENZELLKULTUR
WO2018183848A8 (en) Media for microorganism culture and related compositions and methods
EA200702050A1 (ru) Способ микробиального производства ценного соединения
ATE366803T1 (de) Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit
EP1517987A4 (de) Lungenzellen von baumwollratten zur virenkultur
ATE384121T1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
DE10393303D2 (de) Kultursysteme zur sterilen kontinuierlichen Kultivierung von Zellen
FR2801900B1 (fr) Methode de production de cellules animales adherentes
DE60314904D1 (de) Verfahren zur herstellung von chinoloncarboxylat-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1554374

Country of ref document: EP